Hyperbaric oxygen therapy increases insulin... (2015 study) Skip to main content
Study Diving Hyperb Med 2015

Hyperbaric oxygen therapy increases insulin sensitivity in overweight men with and without type 2 diabetes

Wilkinson D, Nolting M, Mahadi M, Chapman I, Heilbronn L, Diving Hyperb Med, 2015

Tier 2, Indexed

Automatically imported from PubMed based on relevance criteria.

Summary

What Researchers Did

Researchers measured insulin sensitivity and inflammation markers in overweight and obese men, with and without type 2 diabetes, during and after hyperbaric oxygen treatment (HBOT) sessions.

What They Found

In a small study of overweight and obese men, 11 without and 8 with type 2 diabetes, insulin sensitivity measured by glucose infusion rate rose during HBOT by 29 percent in men without diabetes (p equal to 0.01) and by 57 percent in men with type 2 diabetes (p equal to 0.04). The increase was maintained for 30 minutes after HBOT. Two inflammation markers, MCP-1 and TNF-alpha, were lower after HBOT, while IL-6 rose only in men without diabetes. In that group, the IL-6 rise correlated with the rise in insulin sensitivity (r squared 0.72, p equal to 0.004). Final analyses included 10 men without diabetes and 7 with it.

Canadian Relevance

No direct Canadian connection identified.

Study Limitations

The study was small, included only men, and reported no control group, so the findings cannot show lasting benefit or apply to women, and the explanation involving inflammation is only suggested.

This plain-language summary was generated with AI assistance from the study's abstract; it has not been individually reviewed by a clinician. Always consult the source study and a qualified healthcare professional. See our editorial policy.

Was this summary helpful?

Study Details

Study Type Study
Category Uncategorised
Source Pubmed
PubMed ID 25964036
Year Published 2015
Journal Diving Hyperb Med
MeSH Terms Adipose Tissue; Blood Glucose; Chemokine CCL2; Diabetes Mellitus, Type 2; Fasting; Glucose; Humans; Hyperbaric Oxygenation; Insulin; Insulin Resistance; Interleukin-6; Male; Middle Aged; Obesity; Overweight; Receptors, Interleukin-1 Type I; Time Factors; Tumor Necrosis Factor-alpha

Cite This Study

Share

Find a Canadian Clinic Treating Uncategorised

Browse verified hyperbaric facilities across Canada.

View Canadian Facilities

Disclaimer: This study summary is provided for informational and educational purposes only. It does not constitute medical advice. The information presented reflects the findings of the original research authors and may not represent the views of Canada Hyperbarics. Always consult a qualified healthcare professional before making treatment decisions.

Last updated: March 19, 2026 | Reviewed by: Canada Hyperbarics Editorial Team | Editorial process | Research sources | Counts & methodology